School of Medicine
Showing 1-20 of 37 Results
-
Sheila Lahijani, MD, FACLP
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioAfter graduating from Brown Medical School, Dr. Lahijani completed the Combined Internal Medicine/Psychiatry Residency Program at Rush University Medical Center in Chicago. She then served as a physician in the areas of primary care and triple diagnosis (addiction, HIV, mental health). Thereafter, Dr. Lahijani completed the Psychosomatic Medicine Fellowship at the Feinberg School of Medicine of Northwestern University where she worked at the Lurie Comprehensive Cancer Center. During her fellowship, she also served as a psychiatric oncologist at Memorial Sloan Kettering Cancer Center.
Dr. Lahijani joined the faculty of Stanford University School of Medicine in 2015 as a Clinical Assistant Professor of Psychiatry and Behavioral Sciences. Since her initial appointment, Dr. Lahijani has served as the lead psychiatric oncologist at the Stanford Cancer Center where she provides psychiatric consultation services to patients with cancer and collaborates closely with her hematology and oncology colleagues to deliver comprehensive cancer care.
In 2019, she was appointed as the Medical Director of the Stanford Cancer Center Psychosocial Oncology Program where she works in Stanford Cancer Center leadership and oversees the development and operationalization of psychiatric consultation for patients with cancer. Dr. Lahijani also attends on the medical/surgical units, ICUs and in the emergency department at Stanford Hospital and Clinics to provide care for patients with complex medical and psychiatric diagnoses and to teach psychiatry, internal medicine, and neurology trainees. Dr. Lahijani is trained in and administers several psychotherapeutic modalities, including Meaning Centered Psychotherapy and Dignity Therapy, in addition to practicing psychopharmacology.
As Faculty of the Advancing Communication Excellence at Stanford, Dr. Lahijani leads foundational workshops for faculty and staff to advance communication skills with patients, families, and their colleagues. She is committed to developing and contributing to efforts that focus on relationship centered skills and provider wellness.
Her clinical and scholarly interests include the interface of medicine and psychiatry, pharmacology, psycho-oncology, collaborative care models, psychotherapy for the medically ill, interdisciplinary medical education, teaching, and writing. -
Shelby Scott Lazarow, Psy.D.
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Lazarow is a licensed psychologist who specializes in providing clinical care for individuals and couples dealing with acute and chronic medical conditions. She received her doctorate in Clinical Psychology from the PGSP-Stanford Psy.D. Consortium and completed her clinical internship and postdoctoral fellowship at California Pacific Medical Center in the Health Psychology track. Dr. Lazarow is currently serving patients of the Neuropsychiatry Clinic at Stanford University's School of Medicine. In addition to providing individual and couples therapy, Dr. Lazarow has created multiple therapy groups specifically designed for individuals dealing with neurological conditions.
-
Laura C. Lazzeroni, Ph.D.
Professor (Research) of Psychiatry and Behavioral Sciences and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsStatistics/Data Science. I develop & apply models, methods & algorithms for complex data in medical science & biology. I am also interested in the interplay between fundamental statistical properties (e.g. variability, bias, p-values) & how scientists actually use & interpret data. My work in statistical genetics includes: the invention of Plaid bi-clustering for gene expression data; methods for twin, association, & family studies; multiple testing & estimation for high dimensional arrays.
-
Melanie Lean
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioMelanie Lean, Clin.Psych.D. is a Californian licensed clinical psychologist, Clinical Assistant Professor, and assistant director of research in the INSPIRE early psychosis clinic, Stanford University School of Medicine. She provides Cognitive Behavioral Therapy for psychosis (CBTp) within the recovery oriented and trauma informed framework of the INSPIRE clinic. Dr Lean received her doctorate from University College London, UK and completed her postdoctoral fellowship at Stanford University. She is a mixed methods researcher, with over 15 years’ experience in mental health research, working across a range of settings with a focus on severe and enduring mental illness and ways to improve service provision for this population. She has specialized knowledge in self-management and peer support interventions for people with psychosis and has experience working alongside service user researchers in the evaluation and delivery of study interventions. Dr Lean is also trained in psychedelic assisted therapy and works on a range of clinical trials investigating psilocybin for treatment resistant depression.
-
Grace Eun Lee, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioGrace Lee, Ph.D. is a Clinical Assistant Professor and a CA Licensed Clinical Psychologist in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. Dr. Lee specializes in evidence-based, trauma-informed, and compassion-focused care for individuals presenting with psychosis. She is currently providing Cognitive Behavioral Therapy for Psychosis (CBTp), Cognitive Processing Therapy, and Prolonged Exposure Therapy within the INSPIRE Clinic and PTSD Clinic. She also leads trainings in CBTp to providers supporting individuals with psychosis.
-
John Leikauf
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsI am interested in better understanding the heterogeneous cognitive and electrophysiological abnormalities in children with ADHD and the many other conditions that commonly co-occur with ADHD. The long-term goal is to be able to better target treatments to specific deficits in order to promote long-term health and well-being and improve outcomes that matter to individuals and families suffering from these disorders.
-
Anna Lembke, MD
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
BioDr. Anna Lembke received her undergraduate degree in Humanities from Yale University and her medical degree from Stanford University. She is currently Professor and Medical Director of Addiction Medicine, Stanford University School of Medicine. She is also Program Director of the Stanford Addiction Medicine Fellowship, and Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. She is a diplomate of the American Board of Psychiatry and Neurology, and a diplomate of the American Board of Addiction Medicine.
Dr. Lembke was one of the first in the medical community to sound the alarm regarding opioid overprescribing and the opioid epidemic. In 2016, she published her best-selling book on the prescription drug epidemic, "Drug Dealer, MD – How Doctors Were Duped, Patients Got Hooked, and Why It’s So Hard to Stop" (Johns Hopkins University Press, 2016). Her book was highlighted in the New York Times as one of the top five books to read to understand the opioid epidemic (Zuger, 2018).
"Drug Dealer, MD" combines case studies with public policy, cultural anthropology, and neuroscience, to explore the complex relationship between doctors and patients around prescribing controlled drugs. It has had an impact on policy makers and legislators across the nation. Dr. Lembke has testified before Congress and consulted with governors and senators from Kentucky to Missouri to Nevada. She has been a featured guest on Fresh Air with Terry Gross, MSNBC with Chris Hayes, and numerous other media broadcasts.
Using her public platform and her faculty position at Stanford University School of Medicine, Dr. Lembke has developed multiple teaching programs on addiction and safe prescribing, as well as opioid tapering. She has held multiple leadership and mentorship positions and received the Stanford’s Chairman’s Award for Clinical Innovation, and the Stanford Departmental Award for Outstanding Teaching. Dr. Lembke continues to educate policymakers and the public about causes of and solutions for the problem of addiction.
Her latest book, "Dopamine Nation: Finding Balance in the Age of Indulgence" (Dutton/Penguin Random House, August 2021), was an instant New York Times and Los Angeles Times bestseller, and explores how to moderate compulsive overconsumption in a dopamine-overloaded world. -
Douglas F. Levinson, M.D.
Walter E. Nichols, M.D. Professor in the School of Medicine, Emeritus
Current Research and Scholarly InterestsDr. Levinson directs the Program on the Genetics of Brain Function in the Department of Psychiatry and Behavioral Sciences. The program investigates the genetic basis of psychiatric disorders (schizophrenia and major depressive disorder), using genetic association, linkage and resequencing methodologies. In collaboration with Dr. Alice Whittemore, we are also actively engaged in statistical methods testing and development for genetic research.
